Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu No. 1 Pharmaceutical is a comprehensive pharmaceutical enterprise based in Chengdu, China, with a legacy dating back to its founding as a state factory in 1951. The company specializes in the research, development, and high-volume manufacturing of chemical drugs, Active Pharmaceutical Ingredients (APIs), and Traditional Chinese Medicines (TCM). Its product portfolio is particularly strong in the areas of blood volume expanders, cardiovascular treatments, and respiratory medications. Operating from a large, GMP-certified industrial base in the Wenjiang District, the company produces a wide range of dosage forms including large and small-volume injections, tablets, and capsules. Chengdu No. 1 Pharmaceutical serves both the domestic Chinese healthcare market and international markets through its API export business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu No. 1 Pharmaceutical.